IBB ETF holdings (NASDAQ) - Page 4 | MetaTrader

Apri il grafico completo

Panoramica Tutti gli asset Mappa di calore

Principali partecipazioni Market Value Shares Weight %

ACAD ACADIA Pharmaceuticals, Inc. 30.3 M 1.2 M 0.3%

CGON CG oncology, Inc. 28.9 M 407.4 K 0.3%

DNLI Denali Therapeutics, Inc. 27.1 M 1.1 M 0.3%

CRNX Crinetics Pharmaceuticals, Inc. 25.9 M 692.3 K 0.3%

ERAS Erasca, Inc. 24.3 M 1.3 M 0.3%

TNGX Tango Therapeutics, Inc. 23.5 M 751.5 K 0.3%

ADPT Adaptive Biotechnologies Corp. 23.5 M 1.1 M 0.3%

IBRX ImmunityBio, Inc. 23.3 M 2.7 M 0.3%

BEAM Beam Therapeutics, Inc. 22.8 M 664.5 K 0.3%

EWTX Edgewise Therapeutics, Inc. 22.6 M 556.1 K 0.2%

GPCR Structure Therapeutics, Inc. 22.2 M 414.3 K 0.2%

IMVT Immunovant, Inc. 22.1 M 573.7 K 0.2%

IDYA Ideaya Biosciences, Inc. 21.9 M 588.7 K 0.2%

RARE Ultragenyx Pharmaceutical, Inc. 21.2 M 635.3 K 0.2%

DYN Dyne Therapeutics, Inc. 20.8 M 935.5 K 0.2%

ARQT Arcutis Biotherapeutics, Inc. 20.5 M 782.6 K 0.2%

NAMS Newamsterdam Pharma Co. NV 19.2 M 566.1 K 0.2%

GRAL GRAIL, Inc. 19.2 M 280.9 K 0.2%

RLAY Relay Therapeutics, Inc. 19.0 M 1.0 M 0.2%

QURE uniQure NV 18.4 M 399.2 K 0.2%

1
2
3
4
5
6
7
8
...
13

Notizie

UBS elenca 5 motivi chiave per cui le azioni biotech a media capitalizzazione dovrebbero performare bene nel 2026